NURIX THERAPEUTICS, INC. (NRIX) Operating margin 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) operating margin by fiscal year — reported operating income divided by reported revenue.
-340.2%FY2025 · since FY2019: -71.5% → -340.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -340.2% | +50.4 pp |
| FY2024 | -390.5% | -189.1 pp |
| FY2023 | -201.4% | +274.6 pp |
| FY2022 | -476.0% | -79.8 pp |
| FY2021 | -396.3% | -31.6 pp |
| FY2020 | -364.7% | -293.2 pp |
| FY2019 | -71.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice